Global and China Ivosidenib Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.

    This report elaborates on the current development of the Ivosidenib industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Agios Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • 60 Tablets

    • 30 Tablets

    Application:

    • Hospital

    • Pharmacy

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Ivosidenib Industry Overview

      • 1.1.1 Ivosidenib Market Scope and Market Segments

      • 1.1.2 Ivosidenib Industry Characteristics

      • 1.1.3 Global and China Ivosidenib Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Ivosidenib Production Value and Growth Rate (2017-2028)

    • 1.2 Global Ivosidenib Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 60 Tablets

      • 1.2.2 30 Tablets

    • 1.3 Global Ivosidenib Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Pharmacy

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Ivosidenib Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Ivosidenib Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Ivosidenib Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Ivosidenib Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Ivosidenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Ivosidenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Ivosidenib Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Ivosidenib Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Ivosidenib Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Ivosidenib Industry Porter's Five Forces Model Analysis

      • 2.2.3 Ivosidenib Industry PEST Analysis

    • 2.3 Ivosidenib Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Ivosidenib Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Ivosidenib Industry

    Chapter 3 Global and China Ivosidenib Market, by Manufacturer

    • 3.1 Global and China Ivosidenib Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Ivosidenib Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Ivosidenib Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Ivosidenib Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Ivosidenib Market Top 3 Players

    Chapter 4 Global and China Ivosidenib Market, by Type (2017-2028)

    • 4.1 Ivosidenib Market Trend, by Type

    • 4.2 Global Ivosidenib Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Ivosidenib Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Ivosidenib Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Ivosidenib Price Trend, by Type (2017-2028)

    • 4.3 China Ivosidenib Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Ivosidenib Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Ivosidenib Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Ivosidenib Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Ivosidenib Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Ivosidenib Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Ivosidenib Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Ivosidenib Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Ivosidenib Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Ivosidenib Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Ivosidenib Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Ivosidenib Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Ivosidenib Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Ivosidenib Market Analysis

    • 7.1 North America Ivosidenib Market, by Type

    • 7.2 North America Ivosidenib Market, by Application

    • 7.3 North America Ivosidenib Market Analysis and Forecast, by Country

      • 7.3.1 United States Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Ivosidenib Market Analysis

    • 8.1 Europe Ivosidenib Market, by Type

    • 8.2 Europe Ivosidenib Market, by Application

    • 8.3 Europe Ivosidenib Market Analysis and Forecast, by Country

      • 8.3.1 Germany Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Ivosidenib Market Analysis

    • 9.1 APAC Ivosidenib Market, by Type

    • 9.2 APAC Ivosidenib Market, by Application

    • 9.3 APAC Ivosidenib Market Analysis and Forecast, by Country

      • 9.3.1 China Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Ivosidenib Market Analysis

    • 10.1 Latin America, Middle East and Africa Ivosidenib Market, by Type

    • 10.2 Latin America, Middle East and Africa Ivosidenib Market, by Application

    • 10.3 Latin America, Middle East and Africa Ivosidenib Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Ivosidenib Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Ivosidenib Company Profiles

      • 11.1 Agios Pharmaceuticals

        • 11.1.1 Agios Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Agios Pharmaceuticals Ivosidenib Product Profiles, Application and Specification

        • 11.1.3 Agios Pharmaceuticals Ivosidenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Ivosidenib Industry Investment Prospect and Risk Assessment

    • 12.1 Ivosidenib Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Ivosidenib Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure China Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Global Ivosidenib Production Value and Growth Rate (2017-2028)

    • Figure China Ivosidenib Production Value and Growth Rate (2017-2028)

    • Figure Global Ivosidenib Market Size and Growth Rate of 60 Tablets (2017-2028)

    • Figure Global Ivosidenib Market Size and Growth Rate of 30 Tablets (2017-2028)

    • Figure Global Ivosidenib Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Ivosidenib Market Size and Growth Rate of Pharmacy (2017-2028)

    • Figure North America Ivosidenib Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Ivosidenib Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Ivosidenib Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Ivosidenib Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Ivosidenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Ivosidenib Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Ivosidenib Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Ivosidenib Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Ivosidenib Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Ivosidenib Market Share, by Manufacturer in 2021

    • Figure Global and China Ivosidenib Market Share, by Manufacturer in 2022

    • Table Global Ivosidenib Sales Volume, by Type (2017-2028)

    • Table Global Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Figure Global Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Table Global Ivosidenib Sales Value, by Type (2017-2028)

    • Table Global Ivosidenib Sales Value Share, by Type (2017-2028)

    • Figure Global Ivosidenib Price Trend, by Type (2017-2028)

    • Table China Ivosidenib Sales Volume, by Type (2017-2028)

    • Table China Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Figure China Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Table China Ivosidenib Sales Value, by Type (2017-2028)

    • Table China Ivosidenib Sales Value Share, by Type (2017-2028)

    • Figure China Ivosidenib Price Trend, by Type (2017-2028)

    • Table Global Ivosidenib Sales Volume, by Application (2017-2028)

    • Table Global Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure Global Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Table Global Ivosidenib Sales Value, by Application (2017-2028)

    • Table Global Ivosidenib Sales Value Share, by Application (2017-2028)

    • Figure Global Ivosidenib Sales Value Share, by Application (2017-2028)

    • Table China Ivosidenib Sales Volume, by Application (2017-2028)

    • Table China Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure China Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Table China Ivosidenib Sales Value, by Application (2017-2028)

    • Table China Ivosidenib Sales Value Share, by Application (2017-2028)

    • Figure China Ivosidenib Sales Value Share, by Application (2017-2028)

    • Figure China Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • Figure North America Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Ivosidenib Production, Import, Consumption and Export (2017-2022)

    • Table North America Ivosidenib Sales Volume, by Type (2017-2028)

    • Table North America Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Figure North America Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Table North America Ivosidenib Sales Volume, by Application (2017-2028)

    • Table North America Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure North America Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure United States Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure United States Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Canada Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Table Europe Ivosidenib Sales Volume, by Type (2017-2028)

    • Table Europe Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Figure Europe Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Table Europe Ivosidenib Sales Volume, by Application (2017-2028)

    • Table Europe Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure Europe Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure Germany Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure UK Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure UK Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure France Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure France Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Italy Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Spain Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Poland Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Russia Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Table APAC Ivosidenib Sales Volume, by Type (2017-2028)

    • Table APAC Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Figure APAC Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Table APAC Ivosidenib Sales Volume, by Application (2017-2028)

    • Table APAC Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure APAC Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure China Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure China Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Japan Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure India Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure India Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Ivosidenib Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Ivosidenib Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Ivosidenib Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Ivosidenib Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Ivosidenib Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Ivosidenib Sales Value and Growth Rate (2017-2028)

    • Table Agios Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agios Pharmaceuticals Product Profiles, Application and Specification

    • Table Agios Pharmaceuticals Ivosidenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.